Can Histopathologic Features of Duct Cell Carcinoma In Situ of the Breast (DCIS) Be Used To Predict Oncotype DX DCIS Score

被引：0
|
作者：
Fineberg, Susan [1 ]
Fox, Jana [1 ]
Shapiro, Nella [1 ]
Couchonal, Adriana Knopfelmacher [1 ]
机构：
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
166
引用
收藏
页码：44A / 45A
页数：2
相关论文
共 50 条
  • [1] Can Histopathologic Features of Duct Cell Carcinoma In Situ of the Breast (DCIS) Be Used To Predict Oncotype DX DCIS Score
    Fineberg, Susan
    Fox, Jana
    Shapiro, Nella
    Couchonal, Adriana Knopfelmacher
    [J]. MODERN PATHOLOGY, 2015, 28 : 44A - 45A
  • [2] Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score
    Knopfelmacher, Adriana
    Fox, Jana
    Lo, Yungtai
    Shapiro, Nella
    Fineberg, Susan
    [J]. MODERN PATHOLOGY, 2015, 28 (09) : 1167 - 1173
  • [3] Correlation of Pathological Features of Ductal Carcinoma In Situ (DCIS) and Oncotype DCIS Score
    Wallach, J.
    Cate, S.
    Boolbol, S.
    Preeshagul, I.
    Gillego, A.
    Radzio, A.
    Chadha, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S227 - S227
  • [4] How accurately can clinicians predict the Oncotype DX DCIS score?
    Cate, Sarah Patricia
    Gillego, Alyssa
    Chadha, Manjeet
    Rescigno, John
    Gliedman, Paul R.
    Radzio, Agnes
    Boolbol, Susan K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [5] How Accurately Can Clinicians Predict the Oncotype Dx DCIS Score?
    Cate, Sarah
    Cariseo, Elizabeth
    Chadha, Manjeet
    Rescigno, John
    Gliedman, Paul
    Shao, Theresa
    Gillego, Alyssa
    Boolbol, Susan
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 48 - 49
  • [6] Ductal carcinoma in situ (DCIS) of the breast: miRNA deregulation correlates with the Oncotype DX risk score
    Loudig, Olivier
    Ben-Dov, Iddo
    Liu, Christina
    Komforti, Miglena
    Fineberg, Susan
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [7] Molecular Evaluation of Breast Ductal Carcinoma in Situ with Oncotype DX DCIS
    Nofech-Mozes, Sharon
    Hanna, Wedad
    Rakovitch, Eileen
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (05): : 975 - 980
  • [8] Institutional experience with Oncotype DX® DCIS assay in radiation treatment plan of ductal carcinoma in situ (DCIS) of the breast
    Calin, A.
    De Ingunza, L.
    Cebollero, M.
    Lozano, M. A.
    [J]. BREAST, 2017, 32 : S93 - S93
  • [9] Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast
    Douglas-Jones, AG
    Morgan, JM
    Appleton, MAC
    Attanoos, RL
    Caslin, A
    Champ, CS
    Cotter, M
    Dallimore, NS
    Dawson, A
    Fortt, RW
    Griffiths, AP
    Hughes, M
    Kitching, PA
    O'Brien, C
    Rashid, AM
    Stock, D
    Verghese, A
    Williams, DW
    Williams, NW
    Williams, S
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (08) : 596 - 602
  • [10] Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of PatientsWith Ductal Carcinoma In Situ
    Raldow, Ann C.
    Sher, David
    Chen, Aileen B.
    Recht, Abram
    Punglia, Rinaa S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (33) : 3963 - U49
12345